arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

LifeMD, Inc.

LFMD
$3.56 ▲ +0.16 (+4.55%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
58 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

LifeMD, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $168.5M
Dividend Yield
Revenue Growth -23.6%
Op. Margin -17.8%
ROIC -46.9%
FCF / Share $0.01
Trailing P/E
Price / Book 11.3x
FCF Yield 0.2%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

58-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$50.16M
↓ -23.6%
Net Income Profit after all expenses
$-8.87M
↓ -154.9%
Operating Margin Operating profit as % of sales
-17.8%
↓ -46.1% 21th
FCF / Share Free cash flow per share
$0.01
↓ -89.5%
Long-Term Debt Long-term obligations
$15.90M
↑ +47.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
38
Returns
98
Financial Health
35
Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 58 quarters